PD-L1 Negative clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
Sorry, not currently recruiting here
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in participants with previously untreated, locally advanced, inoperable or…
La Jolla, California and other locations
Last updated: